Tag: machine learning ml in the pharmaceutical industry market outlook

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Machine Learning (ML) in The Pharmaceutical Industry Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The market size for machine learning (ML) in the pharmaceutical industry has experienced substantial expansion in recent years. It is forecast to increase from $4.08 billion in 2025 to $5.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. The drivers for this historical growth include augmented research and development investment within pharmaceuticals, the embrace of AI and ML in drug discovery, the rising incidence of chronic diseases, progress in computational biology, and collaborative efforts between pharmaceutical and technology companies.

The market size for machine learning (ML) in the pharmaceutical industry is set to experience significant growth over the coming years. It is projected to expand to $18.71 billion in 2030, with a compound annual growth rate (CAGR) of 35.7%. This growth during the forecast period is primarily driven by the increasing integration of AI in clinical trials, the expanding scope of precision medicine, the greater adoption of real-world data analytics, advancements in cloud-based pharmaceutical platforms, and the ongoing development of personalized therapeutics. Prominent trends expected in this period include predictive drug discovery models, the optimization of clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and the automation of regulatory compliance.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=51802056&type=smp&name=Machine%20Learning%20%28ML%29%20in%20The%20Pharmaceutical%20Industry%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Growth Factors: What’s Supporting Expansion?

The growing acceptance of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical sector. AI refers to computer software designed to imitate human thought processes for intricate tasks like analysis, reasoning, and learning, whereas ML, a component of AI, employs algorithms trained on datasets to create models capable of executing complex functions. Both AI and ML have found application in pharmaceutical technology and the development of drug delivery systems, providing accelerated answers to difficult problems. This technology holds the capacity to revolutionize drug delivery methods, improve instruments for decision-making, and process vast amounts of data for more informed choices. For example, as reported by Forbes, a US-based business magazine, in June 2023, around 432,000 UK organizations, equivalent to one in six, had implemented at least one AI technology. Moreover, at least one AI technology was adopted by 68% of large enterprises, 33% of medium-sized firms, and 15% of small businesses. Consequently, the expanding integration of artificial intelligence (AI) will fuel machine learning (ML) within the pharmaceutical industry.

Machine Learning (ML) in The Pharmaceutical Industry Market Segment Breakdown: Which Categories Lead On Revenue?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Machine Learning (ML) in The Pharmaceutical Industry Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in machine learning within the pharmaceutical industry are focusing on creating user-friendly software platforms, such as drug discovery software, to improve their capabilities in discovering new drugs. Drug discovery software is a broad category encompassing various specialized tools and platforms employed throughout the entire process of identifying and developing novel pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software, which stands as the first software-as-a-service platform to integrate drug discovery and synthesis through the application of generative AI, machine learning, and computer-aided drug design. This platform allows laboratories to pinpoint appropriate drug candidates in a vast chemical space, virtually screen compounds from a universe exceeding 60 billion chemical targets, and assess synthesis routes for drug manufacturing that is safer, more cost-effective, and results in higher yields.

Machine Learning (ML) in The Pharmaceutical Industry Market Leading Players And Competitive Positioning

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

View The Full Machine Learning (ML) in The Pharmaceutical Industry Market Report:

https://thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Geographic Distribution And Regional Opportunities

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Machine Learning (ML) in The Pharmaceutical Industry Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The market size for machine learning (ML) in the pharmaceutical industry has experienced substantial expansion in recent years. It is forecast to increase from $4.08 billion in 2025 to $5.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. The drivers for this historical growth include augmented research and development investment within pharmaceuticals, the embrace of AI and ML in drug discovery, the rising incidence of chronic diseases, progress in computational biology, and collaborative efforts between pharmaceutical and technology companies.

The market size for machine learning (ML) in the pharmaceutical industry is set to experience significant growth over the coming years. It is projected to expand to $18.71 billion in 2030, with a compound annual growth rate (CAGR) of 35.7%. This growth during the forecast period is primarily driven by the increasing integration of AI in clinical trials, the expanding scope of precision medicine, the greater adoption of real-world data analytics, advancements in cloud-based pharmaceutical platforms, and the ongoing development of personalized therapeutics. Prominent trends expected in this period include predictive drug discovery models, the optimization of clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and the automation of regulatory compliance.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=51802056&type=smp&name=Machine%20Learning%20%28ML%29%20in%20The%20Pharmaceutical%20Industry%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Growth Factors: What’s Supporting Expansion?

The growing acceptance of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical sector. AI refers to computer software designed to imitate human thought processes for intricate tasks like analysis, reasoning, and learning, whereas ML, a component of AI, employs algorithms trained on datasets to create models capable of executing complex functions. Both AI and ML have found application in pharmaceutical technology and the development of drug delivery systems, providing accelerated answers to difficult problems. This technology holds the capacity to revolutionize drug delivery methods, improve instruments for decision-making, and process vast amounts of data for more informed choices. For example, as reported by Forbes, a US-based business magazine, in June 2023, around 432,000 UK organizations, equivalent to one in six, had implemented at least one AI technology. Moreover, at least one AI technology was adopted by 68% of large enterprises, 33% of medium-sized firms, and 15% of small businesses. Consequently, the expanding integration of artificial intelligence (AI) will fuel machine learning (ML) within the pharmaceutical industry.

Machine Learning (ML) in The Pharmaceutical Industry Market Segment Breakdown: Which Categories Lead On Revenue?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Machine Learning (ML) in The Pharmaceutical Industry Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in machine learning within the pharmaceutical industry are focusing on creating user-friendly software platforms, such as drug discovery software, to improve their capabilities in discovering new drugs. Drug discovery software is a broad category encompassing various specialized tools and platforms employed throughout the entire process of identifying and developing novel pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software, which stands as the first software-as-a-service platform to integrate drug discovery and synthesis through the application of generative AI, machine learning, and computer-aided drug design. This platform allows laboratories to pinpoint appropriate drug candidates in a vast chemical space, virtually screen compounds from a universe exceeding 60 billion chemical targets, and assess synthesis routes for drug manufacturing that is safer, more cost-effective, and results in higher yields.

Machine Learning (ML) in The Pharmaceutical Industry Market Leading Players And Competitive Positioning

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

View The Full Machine Learning (ML) in The Pharmaceutical Industry Market Report:

https://thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Geographic Distribution And Regional Opportunities

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Machine Learning (ML) in The Pharmaceutical Industry Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The market size for machine learning (ML) in the pharmaceutical industry has experienced substantial expansion in recent years. It is forecast to increase from $4.08 billion in 2025 to $5.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. The drivers for this historical growth include augmented research and development investment within pharmaceuticals, the embrace of AI and ML in drug discovery, the rising incidence of chronic diseases, progress in computational biology, and collaborative efforts between pharmaceutical and technology companies.

The market size for machine learning (ML) in the pharmaceutical industry is set to experience significant growth over the coming years. It is projected to expand to $18.71 billion in 2030, with a compound annual growth rate (CAGR) of 35.7%. This growth during the forecast period is primarily driven by the increasing integration of AI in clinical trials, the expanding scope of precision medicine, the greater adoption of real-world data analytics, advancements in cloud-based pharmaceutical platforms, and the ongoing development of personalized therapeutics. Prominent trends expected in this period include predictive drug discovery models, the optimization of clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and the automation of regulatory compliance.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=51802056&type=smp&name=Machine%20Learning%20%28ML%29%20in%20The%20Pharmaceutical%20Industry%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Growth Factors: What’s Supporting Expansion?

The growing acceptance of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical sector. AI refers to computer software designed to imitate human thought processes for intricate tasks like analysis, reasoning, and learning, whereas ML, a component of AI, employs algorithms trained on datasets to create models capable of executing complex functions. Both AI and ML have found application in pharmaceutical technology and the development of drug delivery systems, providing accelerated answers to difficult problems. This technology holds the capacity to revolutionize drug delivery methods, improve instruments for decision-making, and process vast amounts of data for more informed choices. For example, as reported by Forbes, a US-based business magazine, in June 2023, around 432,000 UK organizations, equivalent to one in six, had implemented at least one AI technology. Moreover, at least one AI technology was adopted by 68% of large enterprises, 33% of medium-sized firms, and 15% of small businesses. Consequently, the expanding integration of artificial intelligence (AI) will fuel machine learning (ML) within the pharmaceutical industry.

Machine Learning (ML) in The Pharmaceutical Industry Market Segment Breakdown: Which Categories Lead On Revenue?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Machine Learning (ML) in The Pharmaceutical Industry Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in machine learning within the pharmaceutical industry are focusing on creating user-friendly software platforms, such as drug discovery software, to improve their capabilities in discovering new drugs. Drug discovery software is a broad category encompassing various specialized tools and platforms employed throughout the entire process of identifying and developing novel pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software, which stands as the first software-as-a-service platform to integrate drug discovery and synthesis through the application of generative AI, machine learning, and computer-aided drug design. This platform allows laboratories to pinpoint appropriate drug candidates in a vast chemical space, virtually screen compounds from a universe exceeding 60 billion chemical targets, and assess synthesis routes for drug manufacturing that is safer, more cost-effective, and results in higher yields.

Machine Learning (ML) in The Pharmaceutical Industry Market Leading Players And Competitive Positioning

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

View The Full Machine Learning (ML) in The Pharmaceutical Industry Market Report:

https://thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Geographic Distribution And Regional Opportunities

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Machine Learning (ML) in The Pharmaceutical Industry Market CAGR Analysis And Future Market Development

The market size of machine learning (ML) in the pharmaceutical sector has expanded at an exponential rate in recent years. It is projected to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. This historical growth has been driven by factors such as higher research and development spending in pharmaceuticals, the integration of AI and ML into drug discovery processes, a growing incidence of chronic illnesses, progress in computational biology, and partnerships between pharmaceutical firms and technology companies.

Over the coming years, the market for machine learning within the pharmaceutical industry is forecast to undergo rapid expansion. By 2030, it is projected to reach $18.71 billion, registering a compound annual growth rate of 35.7%. Several factors are driving this growth during the forecast period, including the increasing incorporation of artificial intelligence into clinical trials, the broadening scope of precision medicine, the growing application of real-world data analytics, progress in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Key trends shaping the period ahead encompass predictive models for drug discovery, optimization of clinical trials, utilization of real-world evidence, adoption of personalized medicine, and automation of regulatory compliance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Growth Momentum: Which Factors Are Influencing Demand?

The growing use of artificial intelligence (AI) is propelling machine learning (ML) forward within the pharmaceutical sector. AI refers to computer software that emulates human cognitive functions to execute intricate tasks like analysis, reasoning, and learning, whereas ML is a specialized branch of AI that relies on data-trained algorithms to generate models capable of handling complex operations. These technologies have already been applied to pharmaceutical innovation and drug delivery design, providing quicker solutions to difficult problems. They hold the promise of revolutionizing how drugs are delivered, improving decision-making instruments, and managing vast volumes of data to enable more efficient choices. For example, as reported by Forbes in June 2023, around 432,000 UK organizations—equivalent to one in six—have integrated at least one AI technology. Furthermore, AI adoption rates include 68% of large enterprises, 33% of medium-sized firms, and 15% of small businesses. Consequently, the rising prevalence of AI is expected to further accelerate ML adoption in the pharmaceutical industry.

Machine Learning (ML) in The Pharmaceutical Industry Market Segment Analysis: What Are The Major Market Categories?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Machine Learning (ML) in The Pharmaceutical Industry Market Trends Reshaping Industry Growth

Leading firms in the pharmaceutical machine learning (ML) sector are concentrating on creating intuitive software platforms—like drug discovery software—to enhance their ability to identify new drugs. Drug discovery software is an expansive category that includes various specialized tools and platforms employed during the identification and development of novel pharmaceutical compounds. As an example, in December 2023, Merck & Co. Inc., an American pharmaceutical corporation, unveiled the AIDDISON drug discovery software. This marks the first software-as-a-service solution that merges drug discovery and synthesis by leveraging generative AI, machine learning, and computer-aided drug design. With this platform, laboratories can identify suitable drug candidates within a vast chemical space, perform virtual screening of compounds drawn from a pool of over 60 billion chemical targets, and assess synthesis pathways to enable safer, more economical, and higher-yielding drug production.

Machine Learning (ML) in The Pharmaceutical Industry Market Leading Companies Driving Competitive Growth

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Access The Complete Machine Learning (ML) in The Pharmaceutical Industry Market Report:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Machine Learning (ML) in The Pharmaceutical Industry Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Machine Learning (ML) in The Pharmaceutical Industry Market Change Between 2026 And 2030?

The market size for machine learning (ML) within the pharmaceutical industry has expanded substantially in recent years. This market is projected to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. The growth observed in prior periods can be attributed to heightened research and development investment in pharmaceuticals, the integration of AI and ML into drug discovery, an increasing prevalence of chronic diseases, progress in computational biology, and partnerships forged between pharmaceutical and technology companies.

The market size for machine learning (ML) within the pharmaceutical industry is expected to show significant growth over the next few years. It is projected to reach $18.71 billion by 2030, with a compound annual growth rate (CAGR) of 35.7%. This growth during the forecast period is driven by the increasing integration of AI in clinical trials, the expansion of precision medicine, the rising use of real-world data analytics, advancements in cloud-based pharmaceutical platforms, and the development of personalized therapeutics. Prominent trends for this period include predictive drug discovery models, the optimization of clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and automation in regulatory compliance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

Which Major Factors Are Contributing To The Development Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

The growing implementation of artificial intelligence (AI) is fueling machine learning (ML) within the pharmaceutical sector. AI refers to computer software designed to simulate human thought processes for complex tasks, including analysis, reasoning, and learning, whereas ML, a subset of AI, utilizes algorithms trained on data to create models capable of performing intricate operations. Both AI and ML have found application in pharmaceutical technology and drug delivery design, providing rapid resolutions to difficult problems. These technologies possess the capacity to revolutionize drug delivery, improve tools for making decisions, and process vast data volumes for better outcomes. As an illustration, in June 2023, Forbes, a US-based business magazine, reported that approximately 432,000 UK organizations—equivalent to one in six—had integrated at least one AI technology. Furthermore, large businesses saw an adoption rate of 68% for at least one AI technology, with medium-sized businesses at 33% and small businesses at 15%. Consequently, the expanding implementation of artificial intelligence (AI) is set to propel machine learning (ML) forward in the pharmaceutical industry.

How Is The Machine Learning (ML) in The Pharmaceutical Industry Market Examined Through Segment Analysis?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Which Trends Are Influencing The Direction Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies engaged in machine learning (ML) within the pharmaceutical industry are concentrating on developing user-friendly software platforms, such as drug discovery software, to enhance their drug discovery capabilities. Drug discovery software serves as a comprehensive term covering various specialized tools and platforms utilized across the entire process of identifying and developing novel pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched its AIDDISON drug discovery software. This represents the first software-as-a-service platform that integrates drug discovery and synthesis by leveraging generative AI, machine learning, and computer-aided drug design. The platform enables laboratories to identify appropriate drug candidates within a vast chemical space, virtually screen compounds from a universe of over 60 billion chemical targets, and evaluate synthesis routes for safer, more cost-effective, and higher-yield drug manufacturing.

Who Are The Major Companies Operating In The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Access The Complete Machine Learning (ML) in The Pharmaceutical Industry Market Report:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Which Region Is The Dominant Market In The Machine Learning (ML) in The Pharmaceutical Industry Market?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Machine Learning (ML) in The Pharmaceutical Industry Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company

Machine Learning Ml In The Pharmaceutical Industry Market Report 2026

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Machine Learning (ML) in The Pharmaceutical Industry Market From 2026 To 2030?

The market size for machine learning (ml) in the pharmaceutical industry has seen significant expansion in recent years. It is anticipated to increase from $4.08 billion in 2025 to $5.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. The historical growth of this market can be attributed to several factors, including heightened research and development investment in pharmaceuticals, the adoption of AI and ML in drug discovery processes, an increasing prevalence of chronic diseases, advancements in computational biology, and strategic collaborations between pharmaceutical and technology companies.

The market size for machine learning (ML) in the pharmaceutical industry is anticipated to demonstrate significant growth in the upcoming years. It is projected to expand to $18.71 billion by 2030, driven by a compound annual growth rate (CAGR) of 35.7%. This increase over the forecast period stems from the increasing integration of AI in clinical trials, the widening scope of precision medicine, the growing adoption of real-world data analytics, developments in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Prominent trends for this period include predictive models for drug discovery, optimization of clinical trials, utilization of real-world evidence data, implementation of personalized medicine, and automation of regulatory compliance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

What Key Factors Are Shaping The Machine Learning (ML) in The Pharmaceutical Industry Market Landscape?

The growing implementation of artificial intelligence (AI) is a key factor driving machine learning (ML) within the pharmaceutical industry. AI refers to computer software designed to emulate human cognitive functions for executing complex operations such as analysis, reasoning, and learning, while ML is a subset of AI that employs algorithms trained on data to create models capable of performing intricate tasks. Both AI and ML have been applied in pharmaceutical technology and drug delivery system design, offering rapid solutions to complex problems. These technologies hold the potential to revolutionize the drug delivery process, enhance tools for decision-making, and manage extensive data volumes for more effective outcomes. For instance, in June 2023, according to Forbes, a US-based business magazine, approximately 432,000 UK organizations, or one in six, had integrated at least one AI technology. Furthermore, a minimum of one AI technology was adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Consequently, the increasing adoption of artificial intelligence (AI) is poised to propel machine learning (ML) forward in the pharmaceutical industry.

How Is The Machine Learning (ML) in The Pharmaceutical Industry Market Organized By Segment Classification?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

What Market Trends Are Affecting The Machine Learning (ML) in The Pharmaceutical Industry Market?

Prominent companies operating with machine learning in the pharmaceutical industry are concentrating on creating user-friendly software platforms, like drug discovery software, to boost their capabilities in drug development. Drug discovery software is a comprehensive term that encompasses various specialized tools and platforms employed across the entire process of identifying and developing novel pharmaceutical drugs. As an illustration, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, unveiled the AIDDISON drug discovery software. This platform is recognized as the first software-as-a-service offering that combines drug discovery and synthesis by utilizing generative AI, machine learning, and computer-aided drug design. It empowers laboratories to identify appropriate drug candidates within a vast chemical space, virtually screen compounds from a universe of over 60 billion chemical targets, and assess synthesis routes for drug manufacturing that is safer, more cost-effective, and achieves higher yields.

Who Are The Industry Participants Involved In The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Get The Full Machine Learning (ML) in The Pharmaceutical Industry Market Report:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Which Region Dominates The Machine Learning (ML) in The Pharmaceutical Industry Market By Market Share?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Machine Learning (ML) in The Pharmaceutical Industry Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company

Machine Learning Ml In The Pharmaceutical Industry Market Report 2026

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Machine Learning (ML) in The Pharmaceutical Industry Market From 2026 To 2030?

The market size for machine learning (ml) in the pharmaceutical industry has seen significant growth in recent years. It is anticipated to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. This historical growth can be linked to several factors, including heightened R&D investment in the pharmaceutical sector, the integration of AI and ML into drug discovery, an increasing incidence of chronic diseases, advancements in computational biology, and collaborations between pharmaceutical and technology companies.

The machine learning (ml) in the pharmaceutical industry market is poised for significant growth in the coming years, with its size expected to reach $18.71 billion by 2030, growing at a compound annual growth rate (CAGR) of 35.7%. This projected expansion is largely due to the increasing incorporation of AI in clinical trials, the broader application of precision medicine, a rise in the use of real-world data analytics, progress in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Throughout the forecast period, key trends will include predictive drug discovery models, optimized clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and automated regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

What Major Drivers Are Influencing Demand In The Machine Learning (ML) in The Pharmaceutical Industry Market?

The expanding adoption of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical industry. AI functions as computer software that replicates human cognitive abilities for intricate tasks such as analysis, reasoning, and learning, while ML is a subset of AI that utilizes algorithms trained on data to generate models capable of performing complex operations. Both AI and ML have been deployed in pharmaceutical technology and drug delivery design, providing accelerated answers to challenging issues. These capabilities have the potential to revolutionize the drug delivery process, enhance tools for decision-making, and manage vast amounts of data for more effective conclusions. For example, in June 2023, Forbes, a US-based business magazine, indicated that approximately 432,000 UK organizations, or one in six, had embraced at least one AI technology. Additionally, at least one AI technology had been adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Thus, the growing implementation of artificial intelligence (AI) will be a driving force for machine learning (ML) in the pharmaceutical industry.

Which Segments Are Included In The Analysis Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Which Trends Are Impacting The Growth Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies in the pharmaceutical industry that utilize machine learning (ML) are concentrating on developing user-friendly software platforms, such as drug discovery software, to bolster their drug discovery capabilities. Drug discovery software is a comprehensive term covering various specialized tools and platforms used throughout the process of identifying and developing new pharmaceutical drugs. For example, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software. This represents the first software-as-a-service platform to integrate drug discovery and synthesis by employing generative AI, machine learning, and computer-aided drug design. The platform allows laboratories to identify fitting drug candidates within an extensive chemical space, virtually screen compounds from a vast universe of over 60 billion chemical targets, and evaluate synthesis routes for manufacturing drugs that are safer, more cost-effective, and yield higher quantities.

Which Key Industry Participants Are Active In The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Read the full machine learning (ml) in the pharmaceutical industry market report here:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Machine Learning (ML) in The Pharmaceutical Industry Market?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Machine Learning (ML) in The Pharmaceutical Industry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13872&type=smp

Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company

Machine Learning Ml In The Pharmaceutical Industry Market Report 2026

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Machine Learning (ML) in The Pharmaceutical Industry Market From 2026 To 2030?

The market size for machine learning (ml) in the pharmaceutical industry has seen significant growth in recent years. It is anticipated to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. This historical growth can be linked to several factors, including heightened R&D investment in the pharmaceutical sector, the integration of AI and ML into drug discovery, an increasing incidence of chronic diseases, advancements in computational biology, and collaborations between pharmaceutical and technology companies.

The machine learning (ml) in the pharmaceutical industry market is poised for significant growth in the coming years, with its size expected to reach $18.71 billion by 2030, growing at a compound annual growth rate (CAGR) of 35.7%. This projected expansion is largely due to the increasing incorporation of AI in clinical trials, the broader application of precision medicine, a rise in the use of real-world data analytics, progress in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Throughout the forecast period, key trends will include predictive drug discovery models, optimized clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and automated regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

What Major Drivers Are Influencing Demand In The Machine Learning (ML) in The Pharmaceutical Industry Market?

The expanding adoption of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical industry. AI functions as computer software that replicates human cognitive abilities for intricate tasks such as analysis, reasoning, and learning, while ML is a subset of AI that utilizes algorithms trained on data to generate models capable of performing complex operations. Both AI and ML have been deployed in pharmaceutical technology and drug delivery design, providing accelerated answers to challenging issues. These capabilities have the potential to revolutionize the drug delivery process, enhance tools for decision-making, and manage vast amounts of data for more effective conclusions. For example, in June 2023, Forbes, a US-based business magazine, indicated that approximately 432,000 UK organizations, or one in six, had embraced at least one AI technology. Additionally, at least one AI technology had been adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Thus, the growing implementation of artificial intelligence (AI) will be a driving force for machine learning (ML) in the pharmaceutical industry.

Which Segments Are Included In The Analysis Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Which Trends Are Impacting The Growth Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies in the pharmaceutical industry that utilize machine learning (ML) are concentrating on developing user-friendly software platforms, such as drug discovery software, to bolster their drug discovery capabilities. Drug discovery software is a comprehensive term covering various specialized tools and platforms used throughout the process of identifying and developing new pharmaceutical drugs. For example, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software. This represents the first software-as-a-service platform to integrate drug discovery and synthesis by employing generative AI, machine learning, and computer-aided drug design. The platform allows laboratories to identify fitting drug candidates within an extensive chemical space, virtually screen compounds from a vast universe of over 60 billion chemical targets, and evaluate synthesis routes for manufacturing drugs that are safer, more cost-effective, and yield higher quantities.

Which Key Industry Participants Are Active In The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Read the full machine learning (ml) in the pharmaceutical industry market report here:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Machine Learning (ML) in The Pharmaceutical Industry Market?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Machine Learning (ML) in The Pharmaceutical Industry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13872&type=smp

Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company

Machine Learning Ml In The Pharmaceutical Industry Market Report 2026

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Machine Learning (ML) in The Pharmaceutical Industry Market From 2026 To 2030?

The market size for machine learning (ml) in the pharmaceutical industry has seen significant growth in recent years. It is anticipated to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. This historical growth can be linked to several factors, including heightened R&D investment in the pharmaceutical sector, the integration of AI and ML into drug discovery, an increasing incidence of chronic diseases, advancements in computational biology, and collaborations between pharmaceutical and technology companies.

The machine learning (ml) in the pharmaceutical industry market is poised for significant growth in the coming years, with its size expected to reach $18.71 billion by 2030, growing at a compound annual growth rate (CAGR) of 35.7%. This projected expansion is largely due to the increasing incorporation of AI in clinical trials, the broader application of precision medicine, a rise in the use of real-world data analytics, progress in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Throughout the forecast period, key trends will include predictive drug discovery models, optimized clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and automated regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

What Major Drivers Are Influencing Demand In The Machine Learning (ML) in The Pharmaceutical Industry Market?

The expanding adoption of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical industry. AI functions as computer software that replicates human cognitive abilities for intricate tasks such as analysis, reasoning, and learning, while ML is a subset of AI that utilizes algorithms trained on data to generate models capable of performing complex operations. Both AI and ML have been deployed in pharmaceutical technology and drug delivery design, providing accelerated answers to challenging issues. These capabilities have the potential to revolutionize the drug delivery process, enhance tools for decision-making, and manage vast amounts of data for more effective conclusions. For example, in June 2023, Forbes, a US-based business magazine, indicated that approximately 432,000 UK organizations, or one in six, had embraced at least one AI technology. Additionally, at least one AI technology had been adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Thus, the growing implementation of artificial intelligence (AI) will be a driving force for machine learning (ML) in the pharmaceutical industry.

Which Segments Are Included In The Analysis Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

Which Trends Are Impacting The Growth Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies in the pharmaceutical industry that utilize machine learning (ML) are concentrating on developing user-friendly software platforms, such as drug discovery software, to bolster their drug discovery capabilities. Drug discovery software is a comprehensive term covering various specialized tools and platforms used throughout the process of identifying and developing new pharmaceutical drugs. For example, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software. This represents the first software-as-a-service platform to integrate drug discovery and synthesis by employing generative AI, machine learning, and computer-aided drug design. The platform allows laboratories to identify fitting drug candidates within an extensive chemical space, virtually screen compounds from a vast universe of over 60 billion chemical targets, and evaluate synthesis routes for manufacturing drugs that are safer, more cost-effective, and yield higher quantities.

Which Key Industry Participants Are Active In The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Read the full machine learning (ml) in the pharmaceutical industry market report here:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Machine Learning (ML) in The Pharmaceutical Industry Market?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Machine Learning (ML) in The Pharmaceutical Industry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13872&type=smp

Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company

Machine Learning Ml In The Pharmaceutical Industry Market Report 2026

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the machine learning (ml) in the pharmaceutical industry market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Machine Learning (ML) in The Pharmaceutical Industry Market?

The market size for machine learning (ml) in the pharmaceutical industry has expanded rapidly in recent years. This market is anticipated to grow from $4.08 billion in 2025 to $5.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. Historically, this expansion has been driven by increasing r&d investment in pharma, adoption of ai and ml in drug discovery, rising prevalence of chronic diseases, advancement in computational biology, and collaboration between pharma and tech companies.

The machine learning (ml) in the pharmaceutical industry market size is projected to experience substantial growth in the upcoming years. It is foreseen to expand to $18.71 billion by 2030, with a compound annual growth rate (CAGR) of 35.7%. This expansion during the forecast period can be linked to the increasing incorporation of AI in clinical trials, the widespread adoption of precision medicine, the rising application of real-world data analytics, advancements in cloud-based pharmaceutical platforms, and the innovation of personalized therapeutics. Prominent trends for the forecast period include predictive models for drug discovery, improvements in clinical trial efficiency, leveraging real-world evidence data, the deployment of personalized medicine, and automated regulatory compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp

What Drivers Are Supporting Technological Adoption In The Machine Learning (ML) in The Pharmaceutical Industry Market?

The expanding integration of artificial intelligence (AI) is a significant catalyst for machine learning (ML) advancements in the pharmaceutical sector. AI, defined as computer software emulating human cognitive functions for intricate operations such as analysis, reasoning, and learning, encompasses ML as a specialized branch that leverages data-trained algorithms to construct models for complex task execution. Both AI and ML have found application in pharmaceutical technology and drug delivery system design, providing accelerated solutions to challenging problems. Their capabilities promise to revolutionize drug delivery processes, enhance tools for decision-making, and manage extensive datasets for more effective outcomes. Illustratively, in June 2023, according to Forbes, a US-based business magazine, an estimated 432,000 UK organizations, equivalent to one in six, had implemented at least one AI technology. This adoption further breaks down to 68% for large businesses, 33% for medium-sized businesses, and 15% for small businesses. Consequently, the rising prevalence of artificial intelligence (AI) will continue to spur machine learning (ML) forward within the pharmaceutical industry.

What Segment Types Are Examined In The Machine Learning (ML) in The Pharmaceutical Industry Market?

The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –

1) By Component: Solution, Services

2) By Deployment: Cloud, On-premise

3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises

Subsegments:

1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications

2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

What Trends Are Expected To Impact The Competitive Landscape Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

Prominent companies leveraging machine learning (ML) within the pharmaceutical sector are concentrating on creating intuitive software platforms, such as drug discovery software, to enhance their drug discovery competencies. Drug discovery software represents a comprehensive category covering a range of specialized instruments and systems employed throughout the process of identifying and developing new pharmaceutical medications. As an illustration, in December 2023, Merck & Co. Inc., a US-based pharmaceutical entity, introduced the AIDDISON drug discovery software, marking the first software-as-a-service platform that integrates drug discovery and synthesis by utilizing generative AI, machine learning, and computer-aided drug design. This system empowers laboratories to identify suitable drug candidates across an immense chemical landscape, virtually screen compounds from a universe of over 60 billion chemical targets, and assess synthesis routes for manufacturing drugs that are safer, more economical, and yield more.

Who Are The Major Companies Operating In The Machine Learning (ML) in The Pharmaceutical Industry Market?

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Machine Learning (ML) in The Pharmaceutical Industry Market?

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Machine Learning (ML) in The Pharmaceutical Industry Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13872&type=smp

Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company

Machine Learning Ml In The Pharmaceutical Industry Market Report 2026

https://www.thebusinessresearchcompany.com/report/machine-learning-ml-in-the-pharmaceutical-industry-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model